It's a Cult | Buy, Sell, or Hold | 3/2/22
Steve Deace Show
00:00
Comorbidity Study - Ivormectin and Mortality
The trials were the first 72 hours, right? That, you know, right off the ground, they would have flunked it. 66 % had coved lung on the a x rays already at that at the starting point when they were given a the ivermectin or the placibo group. When more obese people in the ivermetan arm and they said, lo and behold, there was no reduction in progression to severe illness. So even with their underpowering, it still ended up performing pretty much what it has every time else.
Play episode from 01:22:23
Transcript
